Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $43.17 …

2 days ago · Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are covering the …

$43.17
OFF

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $43.17 …

2 weeks from now

2 days ago · Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are covering the …

americanbankingnews.com

332%
OFF

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus ...

2 weeks from now

5 days ago · Edgewise Therapeutics Stock Performance. Analysts Think There's Still Time to Get in on Edgewise, Up 332%; Shares of NASDAQ EWTX opened at $24.15 on Friday. The …

marketbeat.com

$0.36
OFF

Edgewise Therapeutics (EWTX) Stock Price, News & Analysis

2 weeks from now

Jan 8, 2025 · Edgewise Therapeutics, Inc. (NASDAQ:EWTX) posted its earnings results on Thursday, November, 7th. The company reported ($0.36) earnings per share (EPS) for the …

marketbeat.com

0%
OFF

Edgewise Therapeutics (NASDAQ: EWTX) - The Motley Fool

2 weeks from now

Edgewise Therapeutics (NASDAQ: EWTX) $24.15 (-5.0%) -$1.27. Price as of January 10, 2025, 4:00 p.m. ET ... Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It …

fool.com

$3.12
OFF

Edgewise Therapeutics Inc Stock Price Today | NASDAQ: EWTX …

2 weeks from now

Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a $3.12 billion market cap biopharmaceutical company focused on developing therapies for severe, rare muscle disorders, is navigating a...

investing.com

50%
OFF

Why Edgewise Therapeutics Stock Is Up 50% On Thursday

2 weeks from now

Sep 19, 2024 · Shares of biopharma outfit Edgewise Therapeutics (EWTX-5.00%) soared more than 50% today, reaching a three-year high following an update on the clinical testing of its …

fool.com

332%
OFF

Analysts Think There's Still Time To Get In On Edgewise, Up 332%

2 weeks from now

Sep 25, 2024 · Edgewise Therapeutics (NASDAQ: EWTX) is a small-cap pharmaceutical stock that has been all the rage recently. Shares are up 55% in the last three months and up 332% …

nasdaq.com

$0.36
OFF

Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 7.4

2 weeks from now

2 days ago · Edgewise Therapeutics (NASDAQ:EWTX - Get Free Report) last released its quarterly earnings results on Thursday, November 7th.The company reported ($0.36) EPS for …

marketbeat.com

50%
OFF

Edgewise Therapeutics Soars 50%: Key Reasons Behind The Surge

2 weeks from now

Sep 19, 2024 · Edgewise Therapeutics (NASDAQ: EWTX) is up 50% in a single session and 450% from recent lows for a reason. Its novel, oral, selective treatment for obstructive …

nasdaq.com

FAQs about Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $43.17 … Coupon?

Is Edgewise Therapeutics ewtx a good stock to buy?

Edgewise Therapeutics EWTX is a small-cap pharmaceutical stock that has been all the rage recently. Shares are up 55% in the last three months and up 332% over the past 52 weeks. Edgewise Therapeutics EWTX is up 50% in a single session and 450% from recent lows for a reason. ...

Where is Edgewise Therapeutics Inc headquartered?

The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO. EWTX | Complete Edgewise Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Is Edgewise a pharmaceutical company?

Market Open. Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. ...

What markets is Edgewise Therapeutics focusing on?

Edgewise Therapeutics is focusing on the underserved markets of muscular dystrophy and hypertrophic cardiomyopathy. Its focus on these markets could allow it to become a strong competitor (or perhaps even a market leader) on both fronts. ...

What research coverage has Edgewise Therapeutics received?

Edgewise Therapeutics has received no research coverage in the past 90 days. Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. ...

Can Edgewise's edg-7500 treat hypertrophic cardiomyopathy?

Edgewise's EDG-7500 shows promise as a treatment for hypertrophic cardiomyopathy. This market is currently underserved, largely because many heart drugs can cause other cardiac problems. ...